{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:41:10Z","timestamp":1765284070580,"version":"3.46.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":257,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100029249","name":"Horne Family Foundation","doi-asserted-by":"publisher","award":["313742","150669"],"award-info":[{"award-number":["313742","150669"]}],"id":[{"id":"10.13039\/100029249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epstein\u2013Barr virus (EBV) is a ubiquitous herpesvirus with well-established oncogenic potential, contributing to various malignancies and immune-mediated diseases. Its capacity to infect and immortalize B-cells forms the basis for the generation of lymphoblastoid cell lines (LCLs), which serve as vital models in immunology, virology, and translational research. While conventional LCLs are produced by exogenous EBV infection of peripheral blood mononuclear cells, spontaneous lymphoblastoid cell lines (S-LCLs) can emerge without deliberate viral inoculation, particularly in EBV-seropositive individuals. This review highlights multiple methodologies used to establish S-LCLs, including the use of cyclosporin A, CpG DNA, checkpoint kinase inhibitors, and cytokine modulation, and presents findings from diverse clinical contexts such as autoimmune diseases, post-transplant lymphoproliferative disorders, and cancer. We discuss the biological mechanisms underpinning EBV latency and reactivation, emphasizing the viral transcriptional programmes that drive B-cell transformation and persistence. Additionally, we explore how cytokines, particularly IL-10, support S-LCL survival, and how sodium butyrate and antiviral agents like acyclovir can influence EBV reactivation and replication. The review also considers the diagnostic and therapeutic relevance of LCLs, including their potential as antigen-presenting cells, vaccine platforms, and models for cellular immunotherapies such as CAR T-cells and virus-specific cytotoxic T lymphocytes. By evaluating the generation, molecular features, and immunological significance of S-LCLs, this review underscores their value in modelling EBV-driven disease and advancing novel therapeutic strategies.<\/jats:p>","DOI":"10.1093\/cei\/uxaf061","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:06:38Z","timestamp":1757678798000},"source":"Crossref","is-referenced-by-count":0,"title":["Epstein\u2013Barr virus and spontaneous lymphoblastoid cell lines: establishment, molecular characteristics, immune modulation, and therapeutic insight"],"prefix":"10.1093","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5204-7953","authenticated-orcid":false,"given":"Adekunle A","family":"Adeniran","sequence":"first","affiliation":[{"name":"Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-1700","authenticated-orcid":false,"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[{"name":"Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8872-8711","authenticated-orcid":false,"given":"David","family":"Baker","sequence":"additional","affiliation":[{"name":"Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-4636","authenticated-orcid":false,"given":"Louisa K","family":"James","sequence":"additional","affiliation":[{"name":"Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2025120907362077800_uxaf061-B1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/pathogens1020156","article-title":"Epstein-Barr virus sequence variation\u2014biology and disease","volume":"1","author":"Tzellos","year":"2012","journal-title":"Pathogens"},{"key":"2025120907362077800_uxaf061-B2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fonc.2019.00127","article-title":"Opportunities to target the life cycle of Epstein-Barr virus (EBV) in EBV-associated lymphoproliferative disorders","volume":"9","author":"Dugan","year":"2019","journal-title":"Front Oncol"},{"key":"2025120907362077800_uxaf061-B3","doi-asserted-by":"crossref","first-page":"e0222847","DOI":"10.1371\/journal.pone.0222847","article-title":"Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs","volume":"14","author":"Delecluse","year":"2019","journal-title":"PLoS One"},{"key":"2025120907362077800_uxaf061-B4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coviro.2021.11.013","article-title":"Epigenetic control of the Epstein-Barr lifecycle","volume":"52","author":"Guo","year":"2022","journal-title":"Curr Opin Virol"},{"key":"2025120907362077800_uxaf061-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6464521","article-title":"Epstein-Barr virus- (EBV-) immortalized lymphoblastoid cell lines (LCLs) express high level of CD23 but low CD27 to support their growth","volume":"2019","author":"Yap","year":"2019","journal-title":"Adv Virol"},{"key":"2025120907362077800_uxaf061-B6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-12-386882-4.00006-2","volume-title":"Handbook of pharmacogenomics and stratified medicine","author":"Jeon","year":"2014"},{"key":"2025120907362077800_uxaf061-B7","doi-asserted-by":"crossref","first-page":"i41","DOI":"10.1093\/ije\/dym285","article-title":"EBV immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood","volume":"37","author":"Amoli","year":"2008","journal-title":"Int J Epidemiol"},{"key":"2025120907362077800_uxaf061-B8","first-page":"75","article-title":"Lymphoblastoid cell lines: a continuous in vitro source of cells to study carcinogen sensitivity and DNA repair","volume":"1","author":"Hussain","year":"2012","journal-title":"Int J Mol Cell Med"},{"key":"2025120907362077800_uxaf061-B9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1042\/BIO03801006","article-title":"Human lymphoblastoid cell lines: a valuable tool for personalized medicine research","volume":"38","author":"Gurwitz","year":"2016","journal-title":"Biochem (Lond)"},{"key":"2025120907362077800_uxaf061-B10","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.1111\/jcmm.16992","article-title":"Spontaneous arising of a lymphoblastoid B-cell line harbouring a pre-leukemic DNMT3A mutation in acute myeloid leukaemia cell culture","volume":"25","author":"Hayun","year":"2021","journal-title":"J Cellular Molecular Medi"},{"key":"2025120907362077800_uxaf061-B11","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1099\/0022-1317-68-8-2069","article-title":"Detection of Epstein-Barr virus strain variants in lymphoblastoid cell lines \u201cspontaneously\u201d derived from patients with rheumatoid arthritis, infectious mononucleosis and normal controls","volume":"68","author":"Sculley","year":"1987","journal-title":"J Gen Virol"},{"key":"2025120907362077800_uxaf061-B12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/genes13020353","article-title":"Latent membrane protein 1 (LMP1) from Epstein\u2013Barr virus (EBV) strains M81 and B95.8 modulate miRNA expression when expressed in immortalized human nasopharyngeal cells","volume":"13","author":"M\u00fcller Coan","year":"2022","journal-title":"Genes (Basel)"},{"key":"2025120907362077800_uxaf061-B13","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1182\/bloodadvances.2023012461","article-title":"Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses","volume":"8","author":"Briercheck","year":"2024","journal-title":"Blood Adv"},{"key":"2025120907362077800_uxaf061-B14","doi-asserted-by":"crossref","first-page":"e70269","DOI":"10.1002\/jmv.70269","article-title":"Epstein-Barr virus sequence variations among the understudied nasopharyngeal carcinoma patients of diverse ancestries in Southeast Asia","volume":"97","author":"Tee","year":"2025","journal-title":"J Med Virol"},{"key":"2025120907362077800_uxaf061-B15","doi-asserted-by":"crossref","first-page":"e1012263","DOI":"10.1371\/journal.ppat.1012263","article-title":"Meta-analysis of Epstein-Barr virus genomes in Southern Chinese identifies genetic variants and high risk viral lineage associated with nasopharyngeal carcinoma","volume":"20","author":"Wong","year":"2024","journal-title":"PLoS Pathog"},{"key":"2025120907362077800_uxaf061-B16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0171-2985(81)80058-7","article-title":"Cyclosporin A abrogates proliferation of T cells and generation of suppresser and cytotoxic T-cell function induced by Epstein-Barr virus","volume":"160","author":"Palacios","year":"1981","journal-title":"Immunobiology"},{"key":"2025120907362077800_uxaf061-B17","doi-asserted-by":"crossref","first-page":"2350825","DOI":"10.1002\/eji.202350825","article-title":"The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8+ T cells","volume":"54","author":"Wi\u00dffeld","year":"2024","journal-title":"Eur J Immunol"},{"volume-title":"StatPearls","year":"2025","author":"Tapia","key":"2025120907362077800_uxaf061-B18"},{"key":"2025120907362077800_uxaf061-B19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0008-8749(84)90032-7","article-title":"T-cell-mediated regression of \u201cspontaneous\u201d and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A","volume":"87","author":"Rickinson","year":"1984","journal-title":"Cell Immunol"},{"key":"2025120907362077800_uxaf061-B20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/sj.cgt.7700236","article-title":"Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model","volume":"7","author":"Kubuschok","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"2025120907362077800_uxaf061-B21","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.158.9.4045","article-title":"Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines","volume":"158","author":"Beatty","year":"1997","journal-title":"The Journal of Immunology"},{"key":"2025120907362077800_uxaf061-B22","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.172.6.1625","article-title":"Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells","volume":"172","author":"Go","year":"1990","journal-title":"J Exp Med"},{"key":"2025120907362077800_uxaf061-B23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.chom.2010.11.004","article-title":"An ATM\/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells","volume":"8","author":"Nikitin","year":"2010","journal-title":"Cell Host Microbe"},{"key":"2025120907362077800_uxaf061-B24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1182\/blood.V89.5.1665","article-title":"Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state","volume":"89","author":"Prang","year":"1997","journal-title":"Blood"},{"key":"2025120907362077800_uxaf061-B25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0042-6822(91)90893-G","article-title":"Early events in Epstein-Barr virus infection of human B lymphocytes","volume":"181","author":"Alfieri","year":"1991","journal-title":"Virology"},{"key":"2025120907362077800_uxaf061-B26","doi-asserted-by":"crossref","first-page":"e01723-19","DOI":"10.1128\/mBio.01723-19","article-title":"First days in the life of naive human B lymphocytes infected with Epstein-Barr virus","volume":"10","author":"Pich","year":"2019","journal-title":"mBio"},{"key":"2025120907362077800_uxaf061-B27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/v15040832","article-title":"Epstein\u2013Barr virus B cell growth transformation: the nuclear events","volume":"15","author":"Zhao","year":"2023","journal-title":"Viruses"},{"key":"2025120907362077800_uxaf061-B28","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1128\/JVI.01069-12","article-title":"Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-\u03baB activation","volume":"86","author":"Price","year":"2012","journal-title":"J Virol"},{"key":"2025120907362077800_uxaf061-B29","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1111\/febs.16206","article-title":"Cancers associated with human gammaherpesviruses","volume":"289","author":"Wen","year":"2022","journal-title":"FEBS J"},{"key":"2025120907362077800_uxaf061-B30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2025120907362077800_uxaf061-B31","doi-asserted-by":"crossref","first-page":"e1004656","DOI":"10.1371\/journal.ppat.1004656","article-title":"To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis","volume":"11","author":"Price","year":"2015","journal-title":"PLoS Pathog"},{"key":"2025120907362077800_uxaf061-B32","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1","volume":"94","author":"Levitskaya","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025120907362077800_uxaf061-B33","doi-asserted-by":"crossref","first-page":"e1001151","DOI":"10.1371\/journal.ppat.1001151","article-title":"Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation","volume":"6","author":"Apcher","year":"2010","journal-title":"PLoS Pathog"},{"key":"2025120907362077800_uxaf061-B34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/1348-0421.12155","article-title":"Regulation of Epstein\u2013Barr virus reactivation from latency","volume":"58","author":"Murata","year":"2014","journal-title":"Microbiol Immunol"},{"key":"2025120907362077800_uxaf061-B35","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.ppat.0030194","article-title":"ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus","volume":"3","author":"Yu","year":"2007","journal-title":"PLoS Pathog"},{"key":"2025120907362077800_uxaf061-B36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","article-title":"Regulation of the latent-lytic switch in Epstein-Barr virus","volume":"26","author":"Kenney","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"2025120907362077800_uxaf061-B37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0966-842X(96)81504-6","article-title":"Regulation of Epstein\u2014Barr virus latency by latent membrane protein 2","volume":"4","author":"Longnecker","year":"1996","journal-title":"Trends Microbiol"},{"key":"2025120907362077800_uxaf061-B38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ijc.2910330106","article-title":"Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines","volume":"33","author":"Takada","year":"1984","journal-title":"Intl Journal of Cancer"},{"key":"2025120907362077800_uxaf061-B39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/rmv.1780","article-title":"Switching of EBV cycles between latent and lytic states","volume":"24","author":"Murata","year":"2014","journal-title":"Rev Med Virol"},{"key":"2025120907362077800_uxaf061-B40","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1073\/pnas.1901314116","article-title":"Epstein\u2013Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection","volume":"116","author":"Mrozek-Gorska","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025120907362077800_uxaf061-B41","doi-asserted-by":"crossref","first-page":"e1002697","DOI":"10.1371\/journal.ppat.1002697","article-title":"Epstein-Barr virus infection of Na\u00efve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology","volume":"8","author":"Heath","year":"2012","journal-title":"PLoS Pathog"},{"key":"2025120907362077800_uxaf061-B42","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1349-7006.2011.01924.x","article-title":"Cytokine signatures of transformed B cells with distinct Epstein\u2013Barr virus latencies as a potential diagnostic tool for B cell lymphoma","volume":"102","author":"Miyauchi","year":"2011","journal-title":"Cancer Sci"},{"key":"2025120907362077800_uxaf061-B43","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1038\/s41467-025-59813-z","article-title":"Epstein\u2013Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways","volume":"16","author":"Delecluse","year":"2025","journal-title":"Nat Commun"},{"key":"2025120907362077800_uxaf061-B44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa2301665","article-title":"Survival with axicabtagene ciloleucel in large B-cell lymphoma","volume":"389","author":"Westin","year":"2023","journal-title":"N Engl J Med"},{"key":"2025120907362077800_uxaf061-B45","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor\u2013modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N Engl J Med"},{"key":"2025120907362077800_uxaf061-B46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor\u2013modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"2025120907362077800_uxaf061-B47","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"2025120907362077800_uxaf061-B48","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"2025120907362077800_uxaf061-B49","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"2025120907362077800_uxaf061-B50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/antib14020047","article-title":"Adoptive cell immunotherapy in relapse\/refractory Epstein-Barr virus-driven post-transplant lymphoproliferative disorders","volume":"14","author":"Canichella","year":"2025","journal-title":"Antibodies (Basel)"},{"key":"2025120907362077800_uxaf061-B51","doi-asserted-by":"crossref","first-page":"e1584","DOI":"10.1097\/TXD.0000000000001584","article-title":"CAR T-cell therapy for refractory posttransplantation lymphoproliferative disorder in a kidney transplant patient","volume":"10","author":"Guy","year":"2024","journal-title":"Transplant Direct"},{"key":"2025120907362077800_uxaf061-B52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"2025120907362077800_uxaf061-B53","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"2025120907362077800_uxaf061-B54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/1352458514521888","article-title":"Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis","volume":"20","author":"Pender","year":"2014","journal-title":"Mult Scler"},{"key":"2025120907362077800_uxaf061-B55","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41564-024-01699-6","article-title":"Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease","volume":"9","author":"Soldan","year":"2024","journal-title":"Nat Microbiol"},{"key":"2025120907362077800_uxaf061-B56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003495-198937030-00002","article-title":"Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy","volume":"37","author":"O'Brien","year":"1989","journal-title":"Drugs"},{"key":"2025120907362077800_uxaf061-B57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/B978-0-443-10281-3.00016-6","volume-title":"Basic science in obstetrics and gynaecology","author":"Shehata","year":"2010"},{"key":"2025120907362077800_uxaf061-B58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0002-9343(82)90057-2","article-title":"Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses","volume":"73","author":"Pagano","year":"1982","journal-title":"Am J Med"},{"key":"2025120907362077800_uxaf061-B59","first-page":"1309","article-title":"Drugs for herpesvirus infections","volume":"1","author":"Salvaggio","year":"2017","journal-title":"Infect Dis (Auckl)"},{"key":"2025120907362077800_uxaf061-B60","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/B978-1-4557-4801-3.00045-X","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","author":"Aoki","year":"2015"},{"key":"2025120907362077800_uxaf061-B61","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/B978-1-4160-4044-6.50256-9","volume-title":"Feigin and Cherry\u2019s textbook of pediatric infectious diseases","author":"Demmler-Harrison","year":"2009"},{"key":"2025120907362077800_uxaf061-B62","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1128\/AAC.39.7.1599","article-title":"Activity of penciclovir against Epstein-Barr virus","volume":"39","author":"Bacon","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2025120907362077800_uxaf061-B63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(78)90305-7","article-title":"Sodium butyrate inhibits histone deacetylation in cultured cells","volume":"14","author":"Candido","year":"1978","journal-title":"Cell"},{"key":"2025120907362077800_uxaf061-B64","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1073\/pnas.75.5.2239","article-title":"Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences","volume":"75","author":"Vidali","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025120907362077800_uxaf061-B65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcmd.2006.10.008","article-title":"Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents","volume":"38","author":"Ghosh","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"2025120907362077800_uxaf061-B66","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1128\/JVI.00722-14","article-title":"Activation and repression of Epstein-Barr virus and Kaposi\u2019s sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids","volume":"88","author":"Gorres","year":"2014","journal-title":"J Virol"},{"key":"2025120907362077800_uxaf061-B67","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1093\/nar\/28.20.3918","article-title":"Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation","volume":"28","author":"Chang","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2025120907362077800_uxaf061-B68","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/jvi.67.7.4237-4245.1993","article-title":"cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus","volume":"67","author":"Schepers","year":"1993","journal-title":"J Virol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxaf061\/64273154\/uxaf061.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf061\/64273154\/uxaf061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf061\/64273154\/uxaf061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:36:39Z","timestamp":1765283799000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxaf061\/8254248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxaf061","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"type":"print","value":"0009-9104"},{"type":"electronic","value":"1365-2249"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"uxaf061"}}